The FDA and the Consumer Product Safety Commission have regulations pertaining to drugs. The FDA is responsible for the regulation and oversight of the U.S. drug market. Congress has granted FDA regulatory authority over the formulation, manufacturing, labeling, marketing and promotion; and import / export of drug products into the U.S. Under this current regulatory regime, there are 4 pathways that a company may follow to enter the OTC drug market including 505(b) NDA, 505(b)(1) NDA, 505(b)(2) NDA and ANDA.
This webinar will provide attendees with an overview of the knowledge and skills needed to develop and produce a prescription (Rx) drug product
Course Objectives:
• Gain an understanding of how Rx drug products are regulated in the U.S.
• Learn to distinguish between a potential Rx pharmaceutical product and an OTC drug.
• Understand the difference between the various pathways for commercializing an Rx drug product.
• Know the required elements of a compliant Rx Drug Label and Insert.
• Understand strategies for marketing and promoting Rx drug products, and for mitigating potential enforcement risks.
• Learn the Rx-to-OTC Switch Process.
• Review and evaluate several of FDA’s Warning Letters
Why Should You Attend:
This webinar will discuss U.S. Food and Drug Administration (FDA) regulation of Rx drug products and mitigating the risk of enforcement action in the future. Attendees will gain an understanding of various available strategies for producing and selling an Rx drug product.
Course Outline:
• Gain an understanding of how Rx drug products are regulated in the U.S.
• Learn to distinguish between a potential Rx pharmaceutical product and an OTC drug.
• Understand the difference between the various pathways for commercializing an Rx drug product.
• Know the required elements of a compliant Rx Drug Label and Insert.
• Understand strategies for marketing and promoting Rx drug products, and for mitigating potential enforcement risks.
• Learn the Rx-to-OTC Switch Process.
• Review and evaluate several of FDA’s Warning Letters
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Regulatory affairs managers, directors and associates
• Compliance specialists
• Marketing managers
• Quality professionals
• Document control specialists
• Record retention specialists
Understanding the FDA Compounding Pharmacies Guidance
Get Instant Access 60 Minutes View Program |
Vendor Qualification - Evaluating Vendors & Understanding their Capabilities
Get Instant Access 60 Minutes View Program |
Understanding GMP & cGMP Compliance
Get Instant Access 90 Minutes View Program |
Drug Pharmacy Compounding
Get Instant Access 60 Minutes View Program |
Auditing Quality Suppliers and Vendors
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry